Literature DB >> 19895222

Role of miRNAs in lung cancer.

William C S Cho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19895222     DOI： 10.1586/erm.09.57

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


× No keyword cloud information.
  14 in total

1.  MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

Authors:  Yun Wu; Melissa Crawford; Bo Yu; Yicheng Mao; Serge P Nana-Sinkam; L James Lee
Journal:  Mol Pharm       Date:  2011-06-20       Impact factor: 4.939

2.  MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.

Authors:  Liang Luo; Ting Zhang; Hongbing Liu; Tangfeng Lv; Dongmei Yuan; Yanwen Yao; Yanling Lv; Yong Song
Journal:  Med Oncol       Date:  2011-10-13       Impact factor: 3.064

Review 3.  Detection of miRNAs with a nanopore single-molecule counter.

Authors:  Li-Qun Gu; Meni Wanunu; Michael X Wang; Larry McReynolds; Yong Wang
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

4.  Nanopore-based detection of circulating microRNAs in lung cancer patients.

Authors:  Yong Wang; Dali Zheng; Qiulin Tan; Michael X Wang; Li-Qun Gu
Journal:  Nat Nanotechnol       Date:  2011-09-04       Impact factor: 39.213

5.  Grand Challenges and Opportunities in Deciphering the Role of Non-Coding RNAs in Human Diseases.

Authors:  William C S Cho
Journal:  Front Genet       Date:  2011-01-19       Impact factor: 4.599

6.  MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.

Authors:  Tom Donnem; Christopher G Fenton; Kenneth Lonvik; Thomas Berg; Katrine Eklo; Sigve Andersen; Helge Stenvold; Khalid Al-Shibli; Samer Al-Saad; Roy M Bremnes; Lill-Tove Busund
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

7.  Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis.

Authors:  William C S Cho
Journal:  Front Genet       Date:  2011-02-28       Impact factor: 4.599

8.  [Molecular diagnostics for monitoring and predicting therapeutic effect in cancer].

Authors:  William C S Cho
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-07

9.  [Recent progress in genetic variants associated with cancer and their implications in diagnostics development].

Authors:  William C S Cho
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-01

10.  MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.

Authors:  Jiyun Yang; Haitao Lan; Xiaobing Huang; Baoyu Liu; Yu Tong
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.